Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study.

BACKGROUND Coffee is one of the most widely consumed beverages. We tested the hypothesis that genetically high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof. METHODS We included 93,179 individuals from two large general population cohorts in a Mendelian randomization study. We tested first whether high coffee intake is associated with low risk of obesity, metabolic syndrome and type 2 diabetes, and with related components thereof, in observational analyses; second, whether five genetic variants near the CYP1A1, CYP1A2 and AHR genes are associated with coffee intake; and third, whether the genetic variants are associated with obesity, metabolic syndrome and type 2 diabetes, and with related components thereof. Finally, we tested the genetic association with type 2 diabetes in a meta-analysis including up to 78,021 additional individuals from the DIAGRAM consortium. RESULTS Observationally, high coffee intake was associated with low risk of obesity, metabolic syndrome and type 2 diabetes. Further, high coffee intake was associated with high body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides and total cholesterol and with low high-density lipoprotein cholesterol, but not with glucose levels. In genetic analyses, 9-10 vs 0-3 coffee-intake alleles were associated with 29% higher coffee intake. However, genetically derived high coffee intake was not associated convincingly with obesity, metabolic syndrome, type 2 diabetes, body mass index, waist circumference, weight, height, systolic/diastolic blood pressure, triglycerides, total cholesterol, high-density lipoprotein cholesterol or glucose levels. Per-allele meta-analysed odds ratios for type 2 diabetes were 1.01 (0.98-1.04) for AHR rs4410790, 0.98 (0.95-1.01) for AHR rs6968865, 1.01 (0.99-1.03) for CYP1A1/2 rs2470893, 1.01 (0.98-1.03) for CYP1A1/2 rs2472297 and 0.98 (0.95-1.01) for CYP1A1 rs2472299. CONCLUSIONS High coffee intake was associated observationally with low risk of obesity, metabolic syndrome and type 2 diabetes, and was associated observationally with related components thereof, but with no genetic evidence to support corresponding causal relationships.

[1]  F. Hu,et al.  Coffee consumption and risk of type 2 diabetes: a systematic review. , 2005, JAMA.

[2]  Yuji Hirai,et al.  Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. , 2007, Diabetes research and clinical practice.

[3]  Harshal R. Patil,et al.  Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. , 2013, Journal of the American College of Cardiology.

[4]  David M Nathan,et al.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.

[5]  F J Ingelfinger,et al.  International Journal of Epidemiology , 1973, The New England journal of medicine.

[6]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[7]  T. Takeshita,et al.  Relationship Between Coffee Consumption and Prevalence of Metabolic Syndrome Among Japanese Civil Servants , 2012, Journal of epidemiology.

[8]  Masood Sadiq Butt,et al.  Coffee and its Consumption: Benefits and Risks , 2011, Critical reviews in food science and nutrition.

[9]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[10]  Bo Wang,et al.  Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 , 2010, Drug metabolism reviews.

[11]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[12]  S. Maeda,et al.  Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. , 2011, Endocrine journal.

[13]  Marcus R. Munafò,et al.  Phenotype Refinement Strengthens the Association of AHR and CYP1A1 Genotype with Caffeine Consumption , 2014, PloS one.

[14]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[15]  C. Scaccini,et al.  Role of coffee in modulation of diabetes risk. , 2012, Nutrition reviews.

[16]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[17]  S. Rebello,et al.  Coffee Consumption and Cardiovascular Health: Getting to the Heart of the Matter , 2013, Current Cardiology Reports.

[18]  R. Mägi,et al.  Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. , 2011, Human molecular genetics.

[19]  R. Sinha,et al.  Association of coffee drinking with total and cause-specific mortality. , 2012, The New England journal of medicine.

[20]  F. Hu,et al.  Long-Term Coffee Consumption and Risk of Cardiovascular Disease: A Systematic Review and a Dose–Response Meta-Analysis of Prospective Cohort Studies , 2014, Circulation.

[21]  E. Rimm,et al.  Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption , 2011, PLoS genetics.

[22]  Alvaro Puga,et al.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. , 2009, Biochemical pharmacology.

[23]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[24]  J. Shearer,et al.  Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[25]  A. Hofman,et al.  CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. , 2012, The American journal of clinical nutrition.

[26]  N. Timpson,et al.  The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach , 2012, PLoS medicine.

[27]  J. Liao,et al.  Genetically elevated C-reactive protein and ischemic vascular disease , 2009, Current atherosclerosis reports.

[28]  J. Florez,et al.  The genetics of type 2 diabetes: what have we learned from GWAS? , 2010, Annals of the New York Academy of Sciences.

[29]  J. Manson,et al.  Changes in coffee intake and subsequent risk of type 2 diabetes: three large cohorts of US men and women , 2014, Diabetologia.

[30]  G. Grosso,et al.  Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study , 2014, European Journal of Nutrition.

[31]  F. Hu,et al.  Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis , 2014, Diabetes Care.

[32]  C. Boozer,et al.  Coffee, diabetes, and weight control. , 2006, The American journal of clinical nutrition.

[33]  M. Woodward,et al.  Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. , 2009, Archives of internal medicine.

[34]  Børge G Nordestgaard,et al.  Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. , 2008, JAMA.

[35]  Xiubo Jiang,et al.  Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies , 2014, European Journal of Nutrition.

[36]  M. Feeley,et al.  Effects of caffeine on human health , 2003, Food additives and contaminants.